Open access
Sep 2026
Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors
LCx using combined DNA and RNA NGS testing of CSF is a reliable approach that yields potentially practice-changing clinical information, and suggests that LBx using combined DNA and RNA NGS testing of CSF is a reliable approach that yields potentially practice-changing clinical information.
M. Albitar, Ahmad Charifa, Sally Agersborg et al.
· The journal of liquid biopsy · 0 citations